Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Capitol Health.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as M&A activity heats up
News
ASX Small Caps Lunch Wrap: GDP drama is over, now markets brace for the lack of drama, drama
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Why Goldman recommends these two ASX stocks in the booming diagnostic imaging space
Health & Biotech
ASX Health Stocks: Here’s a highlight from today’s half-year result announcements
Health & Biotech
ASX Health Stocks: Imugene joins forces with Merck and Pfizer for Phase 2 trial on gastric cancer
Experts
Finding the next ASX growth stock, with Martin Hickson from 1851 Capital
News
Half-Yearlies Top 5: Locality Planning Energy is today’s top performer
Health & Biotech
Broken bones are no pretty picture but these ASX stocks help you diagnose or fix them
News
Trading Places: Which ASX shares have institutional investors been buying over January?
News
Rise and Shine: What you need to know before the ASX opens
News
Trading Places: Here are this week’s substantial holder movements
News
Corporate: Capitol Health commits $16m to buying South Australian musculoskeletal imaging provider
Experts
Money Talks: These diagnostic imaging plays paint a pretty picture for investors
Health & Biotech
This health small cap has grown by more than 8000pc in the last decade
Health & Biotech
Integral profit down, revenue up; tells shareholders to keep ignoring takeover
Health & Biotech
